133 related articles for article (PubMed ID: 19131244)
1. Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase.
Stansfield I; Ercolani C; Mackay A; Conte I; Pompei M; Koch U; Gennari N; Giuliano C; Rowley M; Narjes F
Bioorg Med Chem Lett; 2009 Feb; 19(3):627-32. PubMed ID: 19131244
[TBL] [Abstract][Full Text] [Related]
2. Finger-loop inhibitors of the HCV NS5b polymerase. Part 1: Discovery and optimization of novel 1,6- and 2,6-macrocyclic indole series.
McGowan D; Vendeville S; Lin TI; Tahri A; Hu L; Cummings MD; Amssoms K; Berke JM; Canard M; Cleiren E; Dehertogh P; Last S; Fransen E; Van Der Helm E; Van den Steen I; Vijgen L; Rouan MC; Fanning G; Nyanguile O; Van Emelen K; Simmen K; Raboisson P
Bioorg Med Chem Lett; 2012 Jul; 22(13):4431-6. PubMed ID: 22542193
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: potent allosteric inhibitors of the hepatitis C virus NS5B polymerase.
Ding M; He F; Hudyma TW; Zheng X; Poss MA; Kadow JF; Beno BR; Rigat KL; Wang YK; Fridell RA; Lemm JA; Qiu D; Liu M; Voss S; Pelosi LA; Roberts SB; Gao M; Knipe J; Gentles RG
Bioorg Med Chem Lett; 2012 Apr; 22(8):2866-71. PubMed ID: 22424979
[TBL] [Abstract][Full Text] [Related]
4. The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase.
Jackson RW; LaPorte MG; Herbertz T; Draper TL; Gaboury JA; Rippin SR; Patel R; Chunduru SK; Benetatos CA; Young DC; Burns CJ; Condon SM
Bioorg Med Chem Lett; 2011 Jun; 21(11):3227-31. PubMed ID: 21550237
[TBL] [Abstract][Full Text] [Related]
5. II. Novel HCV NS5B polymerase inhibitors: discovery of indole C2 acyl sulfonamides.
Anilkumar GN; Selyutin O; Rosenblum SB; Zeng Q; Jiang Y; Chan TY; Pu H; Wang L; Bennett F; Chen KX; Lesburg CA; Duca J; Gavalas S; Huang Y; Pinto P; Sannigrahi M; Velazquez F; Venkatraman S; Vibulbhan B; Agrawal S; Ferrari E; Jiang CK; Huang HC; Shih NY; George Njoroge F; Kozlowski JA
Bioorg Med Chem Lett; 2012 Jan; 22(1):713-7. PubMed ID: 22104146
[TBL] [Abstract][Full Text] [Related]
6. Tetrahydrobenzothiophene inhibitors of hepatitis C virus NS5B polymerase.
Laporte MG; Lessen TA; Leister L; Cebzanov D; Amparo E; Faust C; Ortlip D; Bailey TR; Nitz TJ; Chunduru SK; Young DC; Burns CJ
Bioorg Med Chem Lett; 2006 Jan; 16(1):100-3. PubMed ID: 16260131
[TBL] [Abstract][Full Text] [Related]
7. Finger loop inhibitors of the HCV NS5b polymerase. Part II. Optimization of tetracyclic indole-based macrocycle leading to the discovery of TMC647055.
Vendeville S; Lin TI; Hu L; Tahri A; McGowan D; Cummings MD; Amssoms K; Canard M; Last S; Van den Steen I; Devogelaere B; Rouan MC; Vijgen L; Berke JM; Dehertogh P; Fransen E; Cleiren E; van der Helm L; Fanning G; Van Emelen K; Nyanguile O; Simmen K; Raboisson P
Bioorg Med Chem Lett; 2012 Jul; 22(13):4437-43. PubMed ID: 22633687
[TBL] [Abstract][Full Text] [Related]
8. Discovery of pentacyclic compounds as potent inhibitors of hepatitis C virus NS5B RNA polymerase.
Habermann J; Capitò E; Ferreira Mdel R; Koch U; Narjes F
Bioorg Med Chem Lett; 2009 Feb; 19(3):633-8. PubMed ID: 19109015
[TBL] [Abstract][Full Text] [Related]
9. 3-heterocyclyl quinolone inhibitors of the HCV NS5B polymerase.
Kumar DV; Rai R; Brameld KA; Riggs J; Somoza JR; Rajagopalan R; Janc JW; Xia YM; Ton TL; Hu H; Lehoux I; Ho JD; Young WB; Hart B; Green MJ
Bioorg Med Chem Lett; 2012 Jan; 22(1):300-4. PubMed ID: 22119470
[TBL] [Abstract][Full Text] [Related]
10. Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors.
Ikegashira K; Oka T; Hirashima S; Noji S; Yamanaka H; Hara Y; Adachi T; Tsuruha J; Doi S; Hase Y; Noguchi T; Ando I; Ogura N; Ikeda S; Hashimoto H
J Med Chem; 2006 Nov; 49(24):6950-3. PubMed ID: 17125247
[TBL] [Abstract][Full Text] [Related]
11. Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.
Talele TT; Arora P; Kulkarni SS; Patel MR; Singh S; Chudayeu M; Kaushik-Basu N
Bioorg Med Chem; 2010 Jul; 18(13):4630-8. PubMed ID: 20627595
[TBL] [Abstract][Full Text] [Related]
12. The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
LaPorte MG; Draper TL; Miller LE; Blackledge CW; Leister LK; Amparo E; Hussey AR; Young DC; Chunduru SK; Benetatos CA; Rhodes G; Gopalsamy A; Herbertz T; Burns CJ; Condon SM
Bioorg Med Chem Lett; 2010 May; 20(9):2968-73. PubMed ID: 20347591
[TBL] [Abstract][Full Text] [Related]
13. Non-nucleoside inhibitors of NS5B polymerase binding to allosteric sites: 3D- QSAR and molecular docking studies.
Cao H; Cao R; Zhang H; Zheng X; Gao D
Curr Med Chem; 2008; 15(15):1462-77. PubMed ID: 18537623
[TBL] [Abstract][Full Text] [Related]
14. HCV NS5B polymerase inhibitors 1: Synthesis and in vitro activity of 2-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivatives.
Wang G; He Y; Sun J; Das D; Hu M; Huang J; Ruhrmund D; Hooi L; Misialek S; Ravi Rajagopalan PT; Stoycheva A; Buckman BO; Kossen K; Seiwert SD; Beigelman L
Bioorg Med Chem Lett; 2009 Aug; 19(15):4476-9. PubMed ID: 19502055
[TBL] [Abstract][Full Text] [Related]
15. HCV NS5B polymerase inhibitors 3: Synthesis and in vitro activity of 3-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-4-hydroxy-2H-quinolizin-2-one derivatives.
Wang G; Zhang L; Wu X; Das D; Ruhrmund D; Hooi L; Misialek S; Ravi Rajagopalan PT; Buckman BO; Kossen K; Seiwert SD; Beigelman L
Bioorg Med Chem Lett; 2009 Aug; 19(15):4484-7. PubMed ID: 19497737
[TBL] [Abstract][Full Text] [Related]
16. I. Novel HCV NS5B polymerase inhibitors: discovery of indole 2-carboxylic acids with C3-heterocycles.
Anilkumar GN; Lesburg CA; Selyutin O; Rosenblum SB; Zeng Q; Jiang Y; Chan TY; Pu H; Vaccaro H; Wang L; Bennett F; Chen KX; Duca J; Gavalas S; Huang Y; Pinto P; Sannigrahi M; Velazquez F; Venkatraman S; Vibulbhan B; Agrawal S; Butkiewicz N; Feld B; Ferrari E; He Z; Jiang CK; Palermo RE; McMonagle P; Huang HC; Shih NY; Njoroge G; Kozlowski JA
Bioorg Med Chem Lett; 2011 Sep; 21(18):5336-41. PubMed ID: 21840715
[TBL] [Abstract][Full Text] [Related]
17. Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus.
Zheng X; Hudyma TW; Martin SW; Bergstrom C; Ding M; He F; Romine J; Poss MA; Kadow JF; Chang CH; Wan J; Witmer MR; Morin P; Camac DM; Sheriff S; Beno BR; Rigat KL; Wang YK; Fridell R; Lemm J; Qiu D; Liu M; Voss S; Pelosi L; Roberts SB; Gao M; Knipe J; Gentles RG
Bioorg Med Chem Lett; 2011 May; 21(10):2925-9. PubMed ID: 21486696
[TBL] [Abstract][Full Text] [Related]
18. Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase.
Shaw AN; Tedesco R; Bambal R; Chai D; Concha NO; Darcy MG; Dhanak D; Duffy KJ; Fitch DM; Gates A; Johnston VK; Keenan RM; Lin-Goerke J; Liu N; Sarisky RT; Wiggall KJ; Zimmerman MN
Bioorg Med Chem Lett; 2009 Aug; 19(15):4350-3. PubMed ID: 19515564
[TBL] [Abstract][Full Text] [Related]
19. Indole RSK inhibitors. Part 1: discovery and initial SAR.
Boyer SJ; Burke J; Guo X; Kirrane TM; Snow RJ; Zhang Y; Sarko C; Soleymanzadeh L; Swinamer A; Westbrook J; Dicapua F; Padyana A; Cogan D; Gao A; Xiong Z; Madwed JB; Kashem M; Kugler S; O'Neill MM
Bioorg Med Chem Lett; 2012 Jan; 22(1):733-7. PubMed ID: 22100312
[TBL] [Abstract][Full Text] [Related]
20. From benzimidazole to indole-5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase. Part 1: indole C-2 SAR and discovery of diamide derivatives with nanomolar potency in cell-based subgenomic replicons.
Beaulieu PL; Gillard J; Jolicoeur E; Duan J; Garneau M; Kukolj G; Poupart MA
Bioorg Med Chem Lett; 2011 Jun; 21(12):3658-63. PubMed ID: 21550240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
